Principal findings of systematic reviews for chronic treatment in childhood asthma
Objective: To summarize the principal findings pertaining to most effective long-term pharmacologic treatment of childhood asthma. Methods: Systematic reviews of randomized clinical trials (SRCTs) on pharmacologic chronic treatment in children (1–18 years) with persistent asthma were retrieved throu...
- Autores:
-
Castro-Rodriguez, Jose A.
Rodrigo, Gustavo J.
Rodriguez-Martinez, Carlos E.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2015
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/3783
- Acceso en línea:
- http://hdl.handle.net/20.500.12495/3783
https://doi.org/10.3109/02770903.2014.971968
https://repositorio.unbosque.edu.co
- Palabra clave:
- Adolescent
AMSTAR
Children
Chronic asthma management
Meta-analysis
Systematic review
Treatment
- Rights
- openAccess
- License
- Acceso abierto
id |
UNBOSQUE2_d757c3977e4bdf27d69090b31ba6124c |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/3783 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
dc.title.translated.spa.fl_str_mv |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
title |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
spellingShingle |
Principal findings of systematic reviews for chronic treatment in childhood asthma Adolescent AMSTAR Children Chronic asthma management Meta-analysis Systematic review Treatment |
title_short |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
title_full |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
title_fullStr |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
title_full_unstemmed |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
title_sort |
Principal findings of systematic reviews for chronic treatment in childhood asthma |
dc.creator.fl_str_mv |
Castro-Rodriguez, Jose A. Rodrigo, Gustavo J. Rodriguez-Martinez, Carlos E. |
dc.contributor.author.none.fl_str_mv |
Castro-Rodriguez, Jose A. Rodrigo, Gustavo J. Rodriguez-Martinez, Carlos E. |
dc.subject.keywords.spa.fl_str_mv |
Adolescent AMSTAR Children Chronic asthma management Meta-analysis Systematic review Treatment |
topic |
Adolescent AMSTAR Children Chronic asthma management Meta-analysis Systematic review Treatment |
description |
Objective: To summarize the principal findings pertaining to most effective long-term pharmacologic treatment of childhood asthma. Methods: Systematic reviews of randomized clinical trials (SRCTs) on pharmacologic chronic treatment in children (1–18 years) with persistent asthma were retrieved through MEDLINE, EMBASE, CINAHL, SCOPUS, and CDSR (up to January2014). Results: One hundred eighty-three SRCTs were searched from databases. Among those, 39 SRCTs were included: two were related to step 1, 24 to step 2, nine to steps 3 and 4, and four to step 5 (according with NAEPP and GINA guidelines). The methodological quality of these SRCTs was determined by using the AMSTAR tool. Results: For step 1: addition of ipatropium bromide to short-acting beta2-agonists does not show any benefit. For step 2: in preschoolers, inhaled corticosteroids (ICSs) reduce severe exacerbations and improve other clinical and lung function parameters. In children, ICSs are superior to leukotriene receptor antagonist (LTRA), cromones, or xantines in reducing severe exacerbations, improving lung function and other clinical outcomes. Fluticasone propionate (FP) is better than beclomethasone dipropionate (BDP) or budesonide only for lung function; but similar to hydrofluoroalkane-BDP or to ciclosenide. Compared to low ICSs doses, moderate doses result in only better lung function, but this is not true for FP. For steps 3 and 4: adding LTRA to ICS confers a small benefit; adding LABA improves lung function but does not reduce exacerbations more than double or higher ICS doses. For step 5: adding omalizumab decreases exacerbations. Conclusions: SRCTs are useful for guiding decisions in chronic childhood asthma treatment. |
publishDate |
2015 |
dc.date.issued.none.fl_str_mv |
2015 |
dc.date.accessioned.none.fl_str_mv |
2020-08-13T19:33:15Z |
dc.date.available.none.fl_str_mv |
2020-08-13T19:33:15Z |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.local.none.fl_str_mv |
Artículo de revista |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
http://purl.org/coar/resource_type/c_6501 |
dc.identifier.issn.none.fl_str_mv |
1532-4303 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/3783 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.3109/02770903.2014.971968 |
dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
https://repositorio.unbosque.edu.co |
identifier_str_mv |
1532-4303 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque |
url |
http://hdl.handle.net/20.500.12495/3783 https://doi.org/10.3109/02770903.2014.971968 https://repositorio.unbosque.edu.co |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.spa.fl_str_mv |
Journal of Asthma, 1532-4303, Vol. 52, Nro. 4, 2015, p. 407-416 |
dc.relation.uri.none.fl_str_mv |
https://www.tandfonline.com/doi/full/10.3109/02770903.2014.971968 |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
dc.rights.creativecommons.none.fl_str_mv |
2014-10-29 |
rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2014-10-29 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Taylor and Francis |
dc.publisher.journal.spa.fl_str_mv |
Journal of Asthma |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/b39c6b98-f375-410b-8870-dba57adff57f/download https://repositorio.unbosque.edu.co/bitstreams/d237aaa4-6356-40b4-bbb5-83b2ccc7d491/download https://repositorio.unbosque.edu.co/bitstreams/de84e961-3d7d-4808-bccb-62d8fa8f404a/download https://repositorio.unbosque.edu.co/bitstreams/896e9b35-4809-4146-aea6-8747d7eb263f/download https://repositorio.unbosque.edu.co/bitstreams/102dbdd1-f15f-4f6d-b71a-e1821dac48e1/download |
bitstream.checksum.fl_str_mv |
05220d8577607d2c21bb2c8708a3b80f 8a4605be74aa9ea9d79846c1fba20a33 7210a811635d1799e7c05fee5d259be7 43ca2dccca77b8ea66b7dd33adf79b78 598eb77ead947a0add04e4fe03183965 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1814100710357204992 |
spelling |
Castro-Rodriguez, Jose A.Rodrigo, Gustavo J.Rodriguez-Martinez, Carlos E.2020-08-13T19:33:15Z2020-08-13T19:33:15Z20151532-4303http://hdl.handle.net/20.500.12495/3783https://doi.org/10.3109/02770903.2014.971968instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengTaylor and FrancisJournal of AsthmaJournal of Asthma, 1532-4303, Vol. 52, Nro. 4, 2015, p. 407-416https://www.tandfonline.com/doi/full/10.3109/02770903.2014.971968Principal findings of systematic reviews for chronic treatment in childhood asthmaPrincipal findings of systematic reviews for chronic treatment in childhood asthmaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85AdolescentAMSTARChildrenChronic asthma managementMeta-analysisSystematic reviewTreatmentObjective: To summarize the principal findings pertaining to most effective long-term pharmacologic treatment of childhood asthma. Methods: Systematic reviews of randomized clinical trials (SRCTs) on pharmacologic chronic treatment in children (1–18 years) with persistent asthma were retrieved through MEDLINE, EMBASE, CINAHL, SCOPUS, and CDSR (up to January2014). Results: One hundred eighty-three SRCTs were searched from databases. Among those, 39 SRCTs were included: two were related to step 1, 24 to step 2, nine to steps 3 and 4, and four to step 5 (according with NAEPP and GINA guidelines). The methodological quality of these SRCTs was determined by using the AMSTAR tool. Results: For step 1: addition of ipatropium bromide to short-acting beta2-agonists does not show any benefit. For step 2: in preschoolers, inhaled corticosteroids (ICSs) reduce severe exacerbations and improve other clinical and lung function parameters. In children, ICSs are superior to leukotriene receptor antagonist (LTRA), cromones, or xantines in reducing severe exacerbations, improving lung function and other clinical outcomes. Fluticasone propionate (FP) is better than beclomethasone dipropionate (BDP) or budesonide only for lung function; but similar to hydrofluoroalkane-BDP or to ciclosenide. Compared to low ICSs doses, moderate doses result in only better lung function, but this is not true for FP. For steps 3 and 4: adding LTRA to ICS confers a small benefit; adding LABA improves lung function but does not reduce exacerbations more than double or higher ICS doses. For step 5: adding omalizumab decreases exacerbations. Conclusions: SRCTs are useful for guiding decisions in chronic childhood asthma treatment.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2014-10-29ORIGINALCastro-Rodriguez, Jose A..pdfCastro-Rodriguez, Jose A..pdfapplication/pdf562005https://repositorio.unbosque.edu.co/bitstreams/b39c6b98-f375-410b-8870-dba57adff57f/download05220d8577607d2c21bb2c8708a3b80fMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/d237aaa4-6356-40b4-bbb5-83b2ccc7d491/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILCastro-Rodriguez, Jose A.pdf.jpgCastro-Rodriguez, Jose A.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/de84e961-3d7d-4808-bccb-62d8fa8f404a/download7210a811635d1799e7c05fee5d259be7MD53Castro-Rodriguez, Jose A..pdf.jpgCastro-Rodriguez, Jose A..pdf.jpgIM Thumbnailimage/jpeg7350https://repositorio.unbosque.edu.co/bitstreams/896e9b35-4809-4146-aea6-8747d7eb263f/download43ca2dccca77b8ea66b7dd33adf79b78MD54TEXTCastro-Rodriguez, Jose A..pdf.txtCastro-Rodriguez, Jose A..pdf.txtExtracted texttext/plain59595https://repositorio.unbosque.edu.co/bitstreams/102dbdd1-f15f-4f6d-b71a-e1821dac48e1/download598eb77ead947a0add04e4fe03183965MD5520.500.12495/3783oai:repositorio.unbosque.edu.co:20.500.12495/37832024-02-06 23:24:17.94restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |